PARP1 and neoplasm: Consequently, we show that PTEN-null/mutant cells show no overt HR-dependent sensitivity to PARP1 inhibition, indicating that any putative PARP-dependent tumor ablation in PTEN-null cells likely involves alternative mechanisms.